OCUL Bull Call Spread Strategy
OCUL (Ocular Therapeutix, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments. Their innovative approach leverages a proprietary bioresorbable hydrogel technology to address a range of eye diseases and conditions. The company currently offers two key products: ReSure Sealant, an ophthalmic device designed to prevent fluid leakage from corneal incisions after cataract surgery, and DEXTENZA, a dexamethasone-based ophthalmic insert used to manage post-surgical inflammation and pain in the eye, as well as to treat allergic conjunctivitis. In addition to their commercial offerings, Ocular Therapeutix is actively developing several product candidates in various clinical stages, including: OTX-TKI, an axitinib intravitreal implant in Phase 1 clinical trials for wet age-related macular degeneration (AMD) and other retinal diseases. OTX-TIC, a travoprost intracameral implant, currently in Phase 2 studies for open-angle glaucoma and ocular hypertension. OTX-CSI, a cyclosporine intracanalicular insert that has successfully completed Phase 2 clinical trials for dry eye disease.
OCUL (Ocular Therapeutix, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $2.24B, a beta of 0.94 versus the broader market, a 52-week range of 6.23-16.44, average daily share volume of 2.8M, a public-listing history dating back to 2014, approximately 325 full-time employees. These structural characteristics shape how OCUL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.94 places OCUL roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a bull call spread on OCUL?
A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width.
OCUL snapshot
As of August 14, 2026, spot at $9.91, ATM IV 131.00%, IV rank 20.30%, expected move 37.56%. The bull call spread on OCUL below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this bull call spread structure on OCUL specifically: OCUL IV at 131.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a OCUL bull call spread, with a market-implied 1-standard-deviation move of approximately 37.56% (roughly $3.72 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OCUL expiries trade a higher absolute premium for lower per-day decay. Position sizing on OCUL should anchor to the underlying notional of $9.91 per share and to the trader's directional view on OCUL stock.
OCUL bull call spread setup
The OCUL bull call spread below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OCUL at $9.91 on that close, the first option leg uses a $10.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OCUL chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OCUL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $10.00 | $1.63 |
| Sell 1 | Call | $10.00 | $1.63 |
OCUL bull call spread risk and reward
- Net Premium / Debit
- $0.00
- Max Profit (per contract)
- $0.00
- Max Loss (per contract)
- $0.00
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit.
OCUL bull call spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bull call spread on OCUL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | $0.00 |
| $2.20 | -77.8% | $0.00 |
| $4.39 | -55.7% | $0.00 |
| $6.58 | -33.6% | $0.00 |
| $8.77 | -11.5% | $0.00 |
| $10.96 | +10.6% | $0.00 |
| $13.15 | +32.7% | $0.00 |
| $15.34 | +54.8% | $0.00 |
| $17.53 | +76.9% | $0.00 |
| $19.72 | +99.0% | $0.00 |
When traders use bull call spread on OCUL
Bull call spreads on OCUL reduce the cost of a bullish OCUL stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
OCUL thesis for this bull call spread
The market-implied 1-standard-deviation range for OCUL extends from approximately $6.19 on the downside to $13.63 on the upside. A OCUL bull call spread caps both the risk and the reward of a bullish position; relative to an outright long call on OCUL, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current OCUL IV rank near 20.30% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on OCUL at 131.00%. As a Healthcare name, OCUL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OCUL-specific events.
OCUL bull call spread positions are structurally moderately bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OCUL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OCUL alongside the broader basket even when OCUL-specific fundamentals are unchanged. Long-premium structures like a bull call spread on OCUL are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current OCUL chain quotes before placing a trade.
Frequently asked questions
- What is a bull call spread on OCUL?
- A bull call spread on OCUL is the bull call spread strategy applied to OCUL (stock). The strategy is structurally moderately bullish: A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width. With OCUL stock at $9.91 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed OCUL chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are OCUL bull call spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the OCUL bull call spread priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 131.00%), the computed maximum profit is $0.00 per contract and the computed maximum loss is $0.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a OCUL bull call spread?
- The breakeven for the OCUL bull call spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The OCUL market-implied 1-standard-deviation expected move in the same options snapshot is approximately 37.56%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bull call spread on OCUL?
- Bull call spreads on OCUL reduce the cost of a bullish OCUL stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
- How does current OCUL implied volatility affect this bull call spread?
- OCUL ATM IV is at 131.00% with IV rank near 20.30%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.